- 바카라사이트 검증 introduces its botulinum toxin and dermal filler products in the Central Asian country for about 120 local medical professionals
- A Korean medical professional delivers a lecture on key features of the products, clinical case studies from Korea, and combination treatment techniques
[by Kang, In Hyo] Hugel, a leading global medical aesthetics company, said on April 21 that has recently hosted a launch seminar for its botulinum toxin Botulax and hyaluronic acid dermal filler Revolax at Holiday Inn Almaty, Kazakhstan, for local dermatologists and plastic surgeons.
바카라사이트 검증, the largest country in Central Asia, is experiencing about 10% annual growth in the aesthetic industry, driven by a stable economy and a significant increase in population. Hugel plans to actively expand in neighboring Commonwealth of Independent States (CIS) building on its debut in 바카라사이트 검증.
The launch event, titled NEXTGEN Beauty Congress, was held for about 120 medical and aesthetic professionals in 바카라사이트 검증 to introduce Botulax and Revolax in the Central Asian country.
Dr. Jonghoon Park, a medical chief at Own Clinic Samseong Branch in Seoul and the guest speaker of the event, delivered a lecture on the clinical efficacy of 바카라사이트 검증 and the application of Revolax for Asian facial structure. He also shared clinical cases from Korea to enhance understanding of the combination treatment of botulinum toxin and dermal filler.
“We’re delighted to launch our flagship products Botulax and Revolax in 바카라사이트 검증, the economic center of Central Asia. We will build a stable presence in the local market with sales and marketing activities that create synergy between the toxin and dermal filler products,” a Hugel official said.